|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Zolinza.(Priority review)(Brief article)
July 01, 2006
Tibolone (Organon).(Non-approvable designations)(Brief article)
July 01, 2006
First-time generic approvals.(FDA Drug Approvals)(Brief article)
July 01, 2006
Trexima.(Approvable designations)(Brief article)
July 01, 2006
Lybrel.(Approvable designations)(Brief article)
July 01, 2006
Talabostat (Point Therapeutics).(Fast-track designations)(Brief articl...
July 01, 2006
Nexavar.(Fast-track designations)(Brief article)
July 01, 2006
MyVax.(Fast-track designations)(Brief article)
July 01, 2006
Selected agents for the treatment of depression.(Drug Watch: A HEADS-U...
July 01, 2006
Panzem.(Orphan drug designations)(Brief article)
July 01, 2006
Asthma patient hospitalization risk more than doubles with long-acting...
July 01, 2006
NSAID use among elderly increases risk of first-time hospitalization f...
July 01, 2006
Use of ACE inhibitors in first trimester raises risk of fetal cardiova...
July 01, 2006
Tysabri.(Safety: labeling updates & new warnings)(Brief article)
July 01, 2006
Paxil/Paxil CR.(Safety labeling updates & new warnings)(Brief article)
July 01, 2006
Spectrum Laboratory Products and FDA notified healthcare professionals...
July 01, 2006
Indiplon: a short-acting GABA-A receptor agonist sedative hypnotic for...
July 01, 2006
Abatacept: the first T-lymphocyte co-stimulation modulator; for use in...
July 01, 2006
Pharmacologic studies review findings on ACE inhibitors, treatment of ...
July 01, 2006
Estrogen alone does not raise risk of breast cancer in hysterectomy pa...
July 01, 2006
Statins, beta blockers may reduce vulnerability of coronary disease pa...
July 01, 2006
Antihypertensives demonstrate benefit in reducing Alzheimer's disease ...
July 01, 2006
Scientific support for off-label prescriptions absent in 73% of cases....
July 01, 2006
TELICAST trial of telithromycin produces split results in asthma treat...
July 01, 2006
Salmeterol/fluticasone combination lowers asthma exacerbations.(News C...
July 01, 2006
SSRIs demonstrate risk reduction for colorectal tumors dependent on do...
July 01, 2006
New ALLHAT findings: diuretic most effective antihypertensive for prev...
July 01, 2006
Nebivolol demonstrates efficacy and favorable safety profile in treatm...
July 01, 2006
Once-daily plasma renin inhibitor aliskiren effective antihypertensive...
July 01, 2006
Valsartan monotherapy reduces hs-CRP levels.(FROM THE 21ST ANNUAL SCIE...
July 01, 2006
Once-daily morphine shows greater improvement than oxycodone BID for c...
July 01, 2006
Anticonvulsant lacosamide exhibits pain reduction in phase 3 diabetic ...
July 01, 2006
Ambrisentan improves exercise capacity in phase 3 trial.(FROM ANNUAL I...
July 01, 2006
2005 leading products by global pharmaceutical sales.(Drug and Formula...
July 01, 2006
Top therapeutic classes contributing to projected drug trend (2006 to ...
July 01, 2006
Medications now in development for mental illness *.(Drug and Formular...
July 01, 2006
FDA safety efforts target counterfeiting, unapproved products, and con...
July 01, 2006
Agomelatine.(Selected literature)(Brief article)
July 01, 2006
Desvenlafaxine.(Selected literature)(Brief article)
July 01, 2006
Gepirone ER.(Selected literature)(Gepirone Extended-Release: New Evide...
July 01, 2006
Nemifitide.(Selected literature)(Brief article)
July 01, 2006
Olanzapine/fluoxetine.(Selected literature)(Brief article)
July 01, 2006
Selected websites.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-S...
July 01, 2006
Icatibant (Kos/Jerini).(Fast-track designations)(Brief article)
July 01, 2006
Panitumumab (Amgen).(Priority review)(Brief article)
July 01, 2006
Saforis.(Priority review)(Brief article)
July 01, 2006
Gardasil: quadrivalent human papillomavirus (Types 6, 11, 16, 18) reco...
July 01, 2006
Wellbutrin XL: bupropion extended-release tablets.(New indications)(Dr...
July 01, 2006
Orapred ODT.(FDA actions in brief)(Brief article)
July 01, 2006
Zetia.(FDA actions in brief)(Brief article)
July 01, 2006
5-iodo-2-pyrimidinone-2'-deoxyribose (ropidoxuridine, Hana Biosciences...
July 01, 2006
Second-generation antisense drug (ISIS 301012, Isis Pharmaceuticals).(...
July 01, 2006
|